AzTrials
AzTrials

ConcussionNCT02501642

Smart Phone Application for Postconcussion Symptom Reduction

A study testing Concussion Coach and Treatment as usual in people with Concussion, run by VA Office of Research and Development at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study will address a very important issue for the VA both currently and in the future -- the high percentage of OIF/OEF/OND Veterans who have been medically diagnosed with a mild traumatic brain injury (mild TBI) and experience distressing symptoms. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Concussion
What is being tested?
Concussion Coach and Treatment as usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
479 participants
Where
2 sitesUnited States
Study dates
1 Dec 2014to 30 Sep 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 or older
  • History of mild TBI (DoD/VA) as determined by trained, experienced staff via interview and medical record review via comprehensive evaluation process within PNS with current symptoms complaints operationally defined as at least two symptoms on the NSI endorsed at the 'moderate' level or a total score on the NSI greater than 25
  • Must speak and read English
  • Not have a history of moderate to severe TBI
  • Not have a self-reported diagnosis of psychosis or be actively suicidal

Who cannot join

  • Subjects who report prior experience with Concussion Coach will also be excluded

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Bay Pines VA Healthcare System, Pay Pines, FL

    Bay Pines, Florida, 33744-0000

  • James A. Haley Veterans' Hospital, Tampa, FL

    Tampa, Florida, 33612

Other trials in United States

About this study

The proposed study will address a very important issue for the VA both currently and in the future -- the high percentage of OIF/OEF/OND Veterans who have been medically diagnosed with a mild traumatic brain injury (mild TBI) and experience distressing symptoms. "Smart phone" mobile applications have become a primary source of information and communication among large percentages of Americans, especially those of the OIF/OEF/OND generation. The proposed study is a 4-year randomized control trial investigating the utility of an interactive, self-management smartphone application, "TBI Coach," one of a suite of mobile applications developed by VA. The primary goal of the proposed study is to evaluate the efficacy of TBI Coach for improving clinical outcomes in those with a history of mild TBI and to determine what aspects of TBI Coach are most useful to Veterans. An overarching goal of this line of research is to improve access among Veterans with mild TBI who still have symptoms months to years after injury.

Objectives. The study will pursue the following objectives:

  1. Evaluate the efficacy of TBI coach for improving clinical outcomes among recipients of TBI Coach.
  2. Determine the aspects of TBI Coach most associated with positive outcomes.
  3. Obtain qualitative information on factors associated with use of TBI coach or with deriving benefit from use of TBI Coach that can be used to inform future modifications of the application and wide scale implementation.
Read the detailed description

Patients who meet eligibility criteria and consent to participate in the study will be randomly assigned to one of two arms, either the Concussion Coach group, which will receive an iPod touch® with the Concussion Coach "Explorer" version, or into the no mobile app control group. Study personnel will explain the purpose of the study, complete the informed consent process, obtain the random treatment assignment from a randomization sheet, and introduce the participant to his/her baseline evaluator. The random assignment to intervention will be accomplished in blocks within each site. While small block sizes allow intervention group sizes to be very similar it may make the allocation process predictable. Therefore to reduce selection bias and achieve balance across the intervention arms sequence list of individual assignments by random block sizes will be generated.

Both groups will be assessed in a pre/post intervention design and will be compensated for their time completing study surveys. During the 3 months that they are involved in the study, the intervention group will be sent (via Concussion Coach) reminders to engage with the app on a weekly basis. Their use (e.g., total time spent on each component of the app) will be collected electronically. Both groups will receive care as usual (meaning their regularly scheduled VA appointments and medications). At the completion of the study, both groups will be encouraged to download the App for their own use, with assistance from the study team if needed.

Description of Intervention \& Training The Concussion Coach is designed to provide psychoeducation, self-assessment, and treatment of PCS symptoms following a mild TBI. The PI and three of the co-investigators were co-developers of Concussion Coach. The public-facing Concussion Coach will be available for free download from a public marketplace and available for use with most mobile devices. The application has the advantage of privacy and anonymity, thus addressing the stigma often expressed as a barrier to seeking treatment. A mirror version of the public version, called Concussion Coach "Explorer Version", will be developed within three months and used for this study. Unlike the public version, it will have the capacity to collect usage information, such as length of time spent on each part of the app, self-report ratings of symptoms and distress, and identification of "favorites" among the self-help tools. These data can be uploaded in a de-identified form to a HIPAA compliant server. Other than the ability to collect data, it will be exactly like the "real" Concussion Coach. The Explorer version will be developed by our collaborators, Vertical Product Development, which developed Concussion Coach, PTSD Coach, and PTSD Explorer version. Explorer versions are especially useful as they allow for unobtrusive, highly detailed, real-time data collection without relying on patient self-report. In addition, the Concussion Coach will be an 'opportunistic' exporter of data. It will upload data to the server whenever it has new data and is in a WiFi zone; participants do not have to have a home wireless network. If they never enter a WiFi area, the investigators will collect their data at study termination when the investigators collect the iPod touch®. The investigators will utilize ohmage, an existing open source technology stack, to port the app to the server.

Conditions
Concussion
Being tested
Concussion Coach, Treatment as usual
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Concussion CoachBehavioural

    smart phone app with educational material on postconcussion symptoms and behavioral self-monitoring/strategies

  • Treatment as usualOther

    Treatment as usual

Study groups in NCT02501642
Study groupRoleWhat they receive
Concussion Coach groupExperimentalAfter informed consent and randomization, participants will complete baseline study measures and will receive an iPod touch® with the Concussion Coach "Explorer" version
Receives: Behavioral: Concussion Coach
Treatment as usualOtherTreatment as usual
Receives: Other: Treatment as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neurobehavioral Symptom Inventory

    The Neurobehavioral Symptom Inventory is a 22-item questionnaire developed to evaluate post-concussive symptom severity following mild TBI (Cicerone and Kalmar 1995). Participants are asked to rate each symptom on a scale of 0-4 (None, Mild, Moderate, Severe, Very Severe) with three different categories of symptoms: Affective/psychological/stress, somatic/physical and cognitive (reflecting three factors). Scores can range from 0-88, with higher scores indicating more severe symptom endorsement.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2015 (estimated)
  2. Study start1 Dec 2014
  3. Primary completion30 Sep 2018
  4. Study completion30 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
479 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02501642
Sponsor's protocol ID
IIR 13-196
Status last verified
Jul 2023
First submitted
2 Jul 2015
Last updated
28 Jul 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: To allow collaboration of information with other interested parties who may be researching the use of Apps for TBI Veterans.

Publications

  • Bradley SE, Haun J, Powell-Cope G, Haire S, Belanger HG. Qualitative assessment of the use of a smart phone application to manage post-concussion symptoms in Veterans with traumatic brain injury. Brain Inj. 2020 Jul 2;34(8):1031-1038. doi: 10.1080/02699052.2020.1771770. Epub 2020 Jun 4.

    PubMed 32493066

Questions about this trial

What is this clinical trial studying?

A study testing Concussion Coach and Treatment as usual in people with Concussion, run by VA Office of Research and Development at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 27 Oct 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neurobehavioral Symptom Inventory (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02501642, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in